跳至主要内容
临床试验/NCT01255059
NCT01255059Unknown不适用

GWAS Research of Lung Cancer by Department of Epidemiology and Biostatistics in Tianjin Medical University Cancer Institute and Hospital

Tianjin Medical University Cancer Institute and Hospital1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2010年6月最近更新:
适应症

试验速览

阶段
不适用
入组人数
500
试验地点
1
主要终点
Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia

研究概览

简要总结

To study the association of Genetic Polymorphisms with Lung Cancer Risk in Tianjin Population.

详细描述

Eligibility criteria:

  • nonsmoker
  • female
  • age between 35 and 80
  • no other types of tumors history
  • frequency-matched cases and controls on gender and age

Outcome measures:

  • OR(odds ratio)
  • RR(risk ratio)
  • CI(confidence interval)
  • SAS software

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
35 Years 至 80 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Non-small cell lung cancer
  • Age from 35 to 80 years old
  • Non-smokers
  • Frequency-matched on age and gender

排除标准

  • Previous medical history of cancer
  • Previous radiotherapy
  • Previous chemotherapy

结局指标

主要结局

Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia

时间窗: 2011-12

A GWAS reported a novel association between the TP63 locus and risk of lung adenocarcinoma; however, this association did not achieve genome-wide significance among never-smoking males or females. We genotyped the TP63 SNPs reported by the previous GWAS (rs10937405 and rs4488809) in 500 never-smoking female lung cancer cases and 500 never-smoking female controls from China. Genetic variation in rs10937405 was associated with lung adenocarcinoma. Our findings provide strong evidence that genetic variation in TP63 is associated with risk of lung adenocarcinoma among non-smoking females.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验